| Name: | Alectinib M1b Metabolite |
| Catalogue No. | VL5710007 |
| CAS No. | N/A |
| Molecular Formula | C₃₀H₃₄N₄O₄ |
| Molecular Weight | 514.62 g/mol |
| Status | In-Stock |
| IUPAC Name | 2-((1-(3-cyano-9-ethyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazol-8-yl)piperidin-4-yl)(2-hydroxyethyl)amino)acetic acid |
| Description | Alectinib M1b Metabolite (CAS No: 1256585-04-2) is a minor metabolite of Alectinib that is a small-molecule ALK inhibitor utilized in the treatment of patients suffering from ALK-positive unresectable, recurrent/advanced Non-small cell lung cancer. |
| References | Sato-Nakai, Mika, et al. “Metabolites of Alectinib in Human: Their Identification and Pharmacological Activity.” Heliyon, vol. 3, no. 7, July 2017, p. e00354, https://doi.org/10.1016/j.heliyon.2017.e00354. |
